Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Expert Review of Hematology|November 25, 2016
Should we be treating lower risk myelofibrosis patients with a JAK2 inhibitor?Guido Lancman, John MascarenhasAnnals of Hematology|September 22, 2021
Impact of rituximab on COVID-19 outcomesHannah Levavi, Guido Lancman, Janice GabriloveHematology/Oncology and Stem Cell Therapy|July 22, 2018
Romiplostim for thrombocytopenia following allogeneic stem cell transplantation: A case seriesGuido Lancman, Alexander Coltoff, Amir SteinbergHematology. American Society of Hematology. Education Program|December 4, 2020
Bispecifics, trispecifics, and other novel immune treatments in myelomaGuido Lancman, Joshua Richter, Ajai ChariInternational Journal of Hematology-Oncology and Stem Cell Research|June 29, 2018
Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCLGuido Lancman, Amir Steinberg, Janice GabriloveTargeted Oncology|October 19, 2020
Targeting Nuclear Export Proteins in Multiple Myeloma TherapyNicholas Theodoropoulos, Guido Lancman, Ajai ChariBlood Cancer Journal|September 12, 2024
Bispecific antibodies in the treatment of multiple myelomaAnup Joseph Devasia, Ajai Chari, Guido LancmanJournal of Hematology & Oncology|October 3, 2020
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemiaGuido Lancman, John Mascarenhas, Michal Bar-NatanCancer Research|October 2, 2023
A Landmark Paper That Introduced Proteasome Inhibition in MyelomaAnup Joseph Devasia, Guido Lancman, A Keith StewartSeizure|May 10, 2014
Nonconvulsive status epilepticus in patients with brain tumorsLara V Marcuse, Guido Lancman, Alexis Demopoulos, et al.Pageof 4